Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -88.07% is in line with its 5-year average of -87.35%, around the middle of its 5-year range (-144.24%–-47.55%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.16% above its 12-month average of -95.89%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -88.07%.
RETURN ON INVESTED CAPITAL (ROIC)
-88.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-95.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-93.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-87.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-98.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.16%
CURRENT VS 3Y AVG
+6.28%
CURRENT VS 5Y AVG
-0.82%
CURRENT VS 10Y AVG
+10.60%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.27%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
-149.69%
vs the sector median at left
Marker Therapeutics, Inc.
Market Cap
$17.17M
Return on Invested Capital (ROIC)
-88.07%
TTM Avg
-95.89%
3Y Avg
-93.96%
5Y Avg
-87.35%
Market Cap
$17.17M
Return on Invested Capital (ROIC)
-73.92%
TTM Avg
-122.57%
3Y Avg
-184.65%
5Y Avg
-161.38%
Market Cap
$17.19M
Return on Invested Capital (ROIC)
-57.74%
TTM Avg
-38.37%
3Y Avg
-49.64%
5Y Avg
-45.59%
Market Cap
$16.76M
Return on Invested Capital (ROIC)
-125.44%
TTM Avg
-125.44%
3Y Avg
-1118.57%
5Y Avg
-719.84%
Market Cap
$16.70M
Return on Invested Capital (ROIC)
-79.20%
TTM Avg
-52.44%
3Y Avg
-44.71%
5Y Avg
-48.21%
Market Cap
$17.61M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
Market Cap
$16.64M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-120.02%
3Y Avg
-101.35%
5Y Avg
-83.66%
Market Cap
$17.79M
Return on Invested Capital (ROIC)
-46.69%
TTM Avg
-40.71%
3Y Avg
-34.73%
5Y Avg
-24.39%
Market Cap
$16.55M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-96.52%
3Y Avg
-105.30%
5Y Avg
-89.17%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | $17.17M | -88.07% | -95.89% | -93.96% | -87.35% |
| PAVmed Inc. (PAVM)vs › | $17.17M | -73.92% | -122.57% | -184.65% | -161.38% |
| Lipocine Inc. (LPCN)vs › | $17.19M | -57.74% | -38.37% | -49.64% | -45.59% |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | -125.44% | -125.44% | -1118.57% | -719.84% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.70M | -79.20% | -52.44% | -44.71% | -48.21% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.61M | N/A | -171.06% | -106.73% | -106.73% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -85.72% | -120.02% | -101.35% | -83.66% |
| Cosmos Health Inc. (COSM)vs › | $17.79M | -46.69% | -40.71% | -34.73% | -24.39% |
| Dyadic International, Inc. (DYAI)vs › | $16.55M | -279.48% | -96.52% | -105.30% | -89.17% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.91M | N/A | -183.21% | -122.71% | -100.21% |
ROIC
-88.1%
ROE
-71.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -88.07% |
| 2026-03-31 | -89.55% |
| 2025-12-31 | -76.74% |
| 2025-09-30 | -80.85% |
| 2025-06-30 | -144.24% |
| 2025-03-31 | -90.93% |
| 2024-12-31 | -59.91% |
| 2024-09-30 | -136.85% |
| 2024-06-30 | -113.32% |
| 2024-03-31 | -108.76% |
| 2023-12-31 | -103.76% |
| 2023-09-30 | -87.88% |
| 2023-06-30 | -90.93% |
| 2023-03-31 | -81.12% |
| 2022-12-31 | -89.82% |
| 2022-09-30 | -102.77% |
| 2022-06-30 | -89.72% |
| 2022-03-31 | -86.63% |
| 2021-12-31 | -71.47% |
| 2021-09-30 | -59.99% |
| 2021-06-30 | -47.55% |
| 2021-03-31 | -36.84% |
| 2020-12-31 | -73.66% |
| 2020-09-30 | -60.50% |
| 2020-06-30 | -55.16% |
| 2020-03-31 | -58.94% |
| 2019-12-31 | -50.55% |
| 2019-09-30 | -317.41% |
| 2019-06-30 | -293.14% |
| 2019-03-31 | -268.73% |
| 2018-12-31 | -249.70% |
| 2018-09-30 | -2153.80% |
| 2018-06-30 | -354.84% |
| 2018-03-31 | -2003.84% |
| 2017-12-31 | -318.39% |
| 2017-09-30 | -177.98% |
| 2017-06-30 | -106.44% |
| 2017-03-31 | -220.84% |
| 2016-12-31 | -137.21% |
| 2016-09-30 | -122.11% |
